NCT05680116

Brief Summary

The aim of our study is to investigate the effect of vibration therapy to be applied to patients undergoing breast cancer surgery and adjuvant radiotherapy on upper extremity joint range of motion, muscle strength, grip strength, pain, functionality, and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 25, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 11, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
Last Updated

December 21, 2023

Status Verified

December 1, 2023

Enrollment Period

4 months

First QC Date

December 25, 2022

Last Update Submit

December 20, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Muscle strength

    Hand-held dynamometer will be used to evaluate shoulder flexion, abduction, external and internal rotation muscles' strength

    6 weeks

  • Range of motion

    Shoulder range of motion will be evaluated by digital goniometer. Shoulder flexion degree, shoulder extension degree, abduction and adduction degree, internal rotation and external rotation degree will be assessed with digital goniometer. The results will be recorded in degrees.

    6 weeks

Secondary Outcomes (7)

  • Pain - Visual Analogue Scale

    6 weeks

  • Grip strength

    6 weeks

  • Disability

    6 weeks

  • Quality of Life- Functional Assessment of Cancer Therapy-Breast" (FACT-B)

    6 weeks

  • Tone - Myoton® PRO

    6 weeks

  • +2 more secondary outcomes

Study Arms (2)

Home based exercise group

ACTIVE COMPARATOR

Patients who will start radiotherapy after breast cancer surgery will be evaluated prior to treatment. During the radiotherapy process, all of the patients will be included in the home exercise program, 5 days a week, 2 sessions a day, each exercise will be 10x2 repetitions. Exercise follow-up of the patients will be provided with weekly routine face-to-face checks. After an average of 6 weeks of radiotherapy, the initial evaluations will be repeated.

Other: Home based exercise

Home based exercise plus vibration therapy group.

EXPERIMENTAL

Patients who will start radiotherapy after breast cancer surgery will be evaluated prior to treatment. During the radiotherapy process, all of the patients will be included in the home exercise program, 5 days a week, 2 sessions a day, each exercise will be 10x2 repetitions. The study group continues their home based exercise, in addition they will receive 30 minutes of Myovolt (Myovolt TM, Myovolt Limited, Christchurch, New Zealand) device which is wearable vibration therapy 2 days a week. The vibration program will continue for 6 weeks, in the form of 2 sessions per week. Intermittent and sinusoidal modes between 20-100 Hz will be used for the vibration frequency.

Device: MYOVOLT (MyovoltTM, Myovolt Limited, Christchurch, New Zealand ) wearable vibration therapy device

Interventions

Patients will wear Myovolt shoulder device twice a week and each session will continue 30minutes. This therapy will apply during the radiotherapy process. The device will be applied on the bare skin of the shoulder area. The first 10 minutes of the 30 minutes will be intermittent vibration, the other 20 minutes will be done in the sinusoidal vibration program. Both programs will be in the range of 20-100 Hz.

Home based exercise plus vibration therapy group.

Patients will do home based exercise during the radiotherapy process. 5 days a week. 2 sessions a day, each exercise will be 10x2 repetitions

Home based exercise group

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with breast cancer, undergoing breast-conserving surgery or having a total mastectomy and undergoing axillary lymph node dissection during surgery
  • Cases that will start radiotherapy after surgery
  • Being over 18 years old
  • Absence of limitation in shoulder joint range of motion in preoperative evaluations.
  • No speech and hearing problems
  • Volunteering of the patients included in the study

You may not qualify if:

  • Having previously undergone ipsilateral or contralateral breast cancer surgery
  • Presence of active or metastatic cancer focus
  • Presence of a neurological disease or orthopedic surgery affecting upper extremity functionality
  • Carrying a pacemaker
  • Presence of infection and open wound
  • Finding a post-surgical drain
  • Cases with mental and cooperation problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Professor Cemil Taşcıoğlu Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

  • Feyzioglu O, Dincer S, Yilmaz BD, Saldiran TC, Ozturk O. Effects of Vibration Therapy on Muscle Strength, Shoulder Range of Motion, and Muscle Biomechanical Properties in Patients With Breast Cancer Undergoing Radiotherapy: A Randomized Controlled Trial. Am J Phys Med Rehabil. 2025 Apr 1;104(4):325-334. doi: 10.1097/PHM.0000000000002664. Epub 2024 Nov 14.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Özlem Feyzioğlu, PhD

    Acibadem University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asistant Professor

Study Record Dates

First Submitted

December 25, 2022

First Posted

January 11, 2023

Study Start

February 1, 2023

Primary Completion

June 1, 2023

Study Completion

June 15, 2023

Last Updated

December 21, 2023

Record last verified: 2023-12

Locations